12:05 PM
 | 
Jun 20, 2018
 |  BC Innovations  |  Distillery Therapeutics

Endocrine/Metabolic

INDICATION: Diabetes

Patient sample and mouse studies suggest inhibiting ANGPTL4 could help treat insulin resistance. In non-diabetic individuals, a loss-of-function mutation in ANGPTL4 was associated with low levels of fasting...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >